102 related articles for article (PubMed ID: 34367063)
1. Cardiovascular Risk Factor Status in Hospitalized Patients With Type 2 Diabetes in China.
Yang X; Liu Q; Fan Y; Ding L; Wang R; Hu G; Liu M
Front Endocrinol (Lausanne); 2021; 12():664183. PubMed ID: 34367063
[TBL] [Abstract][Full Text] [Related]
2. Optimal glycaemic and blood pressure but not lipid targets are related to a lower prevalence of diabetic microvascular complications.
Bashir M; Elhadd T; Dabbous Z; Gul W; Salameh O; Siddiqui M; Al-Muhannadi H; Petropoulos I; Khan A; Ponirakis G; Malik RA
Diabetes Metab Syndr; 2021; 15(5):102241. PubMed ID: 34390975
[TBL] [Abstract][Full Text] [Related]
3. Racial disparities in cardiovascular risk factor control in an underinsured population with Type 2 diabetes.
Wang Y; Katzmarzyk PT; Horswell R; Zhao W; Li W; Johnson J; Ryan DH; Hu G
Diabet Med; 2014 Oct; 31(10):1230-6. PubMed ID: 24750373
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of cardiovascular risk factors in non-menopausal and postmenopausal inpatients with type 2 diabetes mellitus in China.
Zhou H; Zhang C; Ni J; Han X
BMC Endocr Disord; 2019 Oct; 19(1):98. PubMed ID: 31601203
[TBL] [Abstract][Full Text] [Related]
5. Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery disease.
Li S; Zhang Y; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q; Li JJ
J Diabetes Complications; 2016; 30(1):115-20. PubMed ID: 26481154
[TBL] [Abstract][Full Text] [Related]
6. Greater macrovascular and microvascular morbidity from type 2 diabetes in northern compared with southern China: A cross-sectional study.
Wang L; Xing Y; Yu X; Ming J; Liu X; Li X; Fu J; Zhou J; Gao B; Hu D; Pan C; Ji L; Ji Q
J Diabetes Investig; 2020 Sep; 11(5):1285-1294. PubMed ID: 32227466
[TBL] [Abstract][Full Text] [Related]
7. A cross-sectional cohort study with microvascular complications in patients with type 2 diabetes with and without hypothyroidism.
Johnson L; Rayner B
Cardiovasc J Afr; 2020 Jan/Feb 23; 31(1):5-8. PubMed ID: 31469387
[TBL] [Abstract][Full Text] [Related]
8. The impact of serum lipids on risk for microangiopathy in patients with type 2 diabetes mellitus.
Toth PP; Simko RJ; Palli SR; Koselleck D; Quimbo RA; Cziraky MJ
Cardiovasc Diabetol; 2012 Sep; 11():109. PubMed ID: 22978715
[TBL] [Abstract][Full Text] [Related]
9. Concomitant macro and microvascular complications in diabetic nephropathy.
Alwakeel JS; Al-Suwaida A; Isnani AC; Al-Harbi A; Alam A
Saudi J Kidney Dis Transpl; 2009 May; 20(3):402-9. PubMed ID: 19414942
[TBL] [Abstract][Full Text] [Related]
10. Blood Pressure Management in Adults With Type 2 Diabetes: Insights From the Diabetes Mellitus Status in Canada (DM-SCAN) Survey.
Grenier J; Goodman SG; Leiter LA; Langer A; Teoh H; Bhatt DL; Cheng AYY; Tan MK; Ransom T; Connelly KA; Yan AT
Can J Diabetes; 2018 Apr; 42(2):130-137. PubMed ID: 28552652
[TBL] [Abstract][Full Text] [Related]
11. Type 2 diabetes mellitus: prevention of macrovascular complications.
Meeuwisse-Pasterkamp SH; van der Klauw MM; Wolffenbuttel BH
Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
[TBL] [Abstract][Full Text] [Related]
12. The long-term effectiveness of metabolic control on cardiovascular disease in patients with diabetes in a real-world health care setting - A prospective diabetes management study.
Chen S; Hou X; Zhou X; Yu J; Xue H; Hu G; Sun Y; Chen P; Wu J; Liang Y; Bao Y; Jia W
Prim Care Diabetes; 2020 Jun; 14(3):274-281. PubMed ID: 31606312
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of micro and macroangiopatic chronic complications and their risk factors in the care of out patients with type 2 diabetes mellitus].
Scheffel RS; Bortolanza D; Weber CS; Costa LA; Canani LH; Santos KG; Crispim D; Roisenberg I; Lisbôa HR; Tres GS; Tschiedel B; Gross JL
Rev Assoc Med Bras (1992); 2004; 50(3):263-7. PubMed ID: 15499476
[TBL] [Abstract][Full Text] [Related]
14. Microvascular and macrovascular complications in diabetic nephropathy patients referred to nephrology clinic.
Al-Wakeel JS; Hammad D; Al Suwaida A; Mitwalli AH; Memon NA; Sulimani F
Saudi J Kidney Dis Transpl; 2009 Jan; 20(1):77-85. PubMed ID: 19112222
[TBL] [Abstract][Full Text] [Related]
15. Crossing family histories of diabetes and cardiovascular disease leads to unexpected outcomes in diabetic offspring.
Hermans MP; Ahn SA; Rousseau MF
J Diabetes; 2019 Apr; 11(4):301-308. PubMed ID: 30105804
[TBL] [Abstract][Full Text] [Related]
16. Characteristics of patients with type 2 diabetes of short duration in Poland: Rationale, design and preliminary results of the ARETAEUS1 study.
Bała MM; Płaczkiewicz-Jankowska E; Topór-Madry R; Leśniak W; Wiercińska E; Szczepaniak P; Jaeschke R; Sieradzki J; Grzeszczak W; Banasiak W;
Pol Arch Med Wewn; 2009 Sep; 119(9):533-40. PubMed ID: 19776697
[TBL] [Abstract][Full Text] [Related]
17. Effect of intensive multifactorial treatment on the intima-media thickness of large arteries in patients with new-onset type 2 diabetes mellitus.
Zhao XH; Xu ZR; Zhang Q; Gu HF; Yang YM
J Zhejiang Univ Sci B; 2012 May; 13(5):378-85. PubMed ID: 22556176
[TBL] [Abstract][Full Text] [Related]
18. Total homocysteine levels relation with chronic complications of diabetes, body composition, and other cardiovascular risk factors in a population of patients with diabetes mellitus type 2.
de Luis DA; Fernandez N; Arranz ML; Aller R; Izaola O; Romero E
J Diabetes Complications; 2005; 19(1):42-6. PubMed ID: 15642489
[TBL] [Abstract][Full Text] [Related]
19. Secondary prevention of diabetic patients with coronary artery disease in cardiac rehabilitation: risk factors, treatment and target level attainment.
Völler H; Reibis R; Pittrow D; Jannowitz C; Wegscheider K; Karmann B; Bestehorn K
Curr Med Res Opin; 2009 Apr; 25(4):879-90. PubMed ID: 19254205
[TBL] [Abstract][Full Text] [Related]
20. Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes.
Chowdhury TA; Lasker SS
QJM; 2002 Apr; 95(4):241-6. PubMed ID: 11937651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
